Missouri Valley Cancer Consortium

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

By volume: Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Chemotherapy-related skin toxicity.

1. 1 Cancer Treatment and Pharmacology Oncology 3 works
2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
3. 3 Lung Cancer Research Studies Oncology 1 works
4. 4 Chemotherapy-related skin toxicity Dermatology 1 works
5. 5 Cancer survivorship and care Oncology 1 works
6. 6 Estrogen and related hormone effects Genetics 1 works
7. 7 Breast Cancer Treatment Studies Cancer Research 1 works
8. 8 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
9. 9 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
10. 10 Colorectal Cancer Treatments and Studies Oncology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 74% lower than in 2013–2017.

• University of Nebraska Medical Center
• Creighton University
• University of Nebraska at Omaha
• Engineering Systems (United States)
• Nebraska Medical Center
• Clarkson College
• CHI Health Creighton University Medical Center - Bergan Mercy
• Children's Hospital & Medical Center